Analysis of Reddit Post on UNH (Pre-Berkshire 13F) and LULU's Growth Prospects

On November 14, 2025 (EST), a Reddit post argued

is attractively priced near $320, citing Berkshire Hathaway’s average cost of ~$314 and an upcoming 13F filing. The post also remained bullish on due to potential China deals, upcoming earnings, buybacks, and a strong balance sheet—despite recent guidance-driven weakness.

• UNH
  : Closed at $321.86 on 2025-11-14, down 1.56% day-over-day (volume: ~8.65M shares) [0]. This underperformed the Healthcare sector, which was flat (+0.0759%) that day [0].
• LULU
  : Closed at $170.68 on 2025-11-14, up 2.93% day-over-day (volume: ~1.95M shares) [0]. This outperformed the Consumer Cyclical sector (+1.02153%) [0].

• Energy (+3.12%) and Financial Services (+1.40%) led gains on 2025-11-14, while Communication Services (-2.22%) and Basic Materials (-0.94%) lagged [0].

• Berkshire’s Position
  : Berkshire initiated a $2B UNH position in Q2-2025, buying during a 40% stock drop due to rising medical costs and billing investigations [1]. The Reddit post references Berkshire’s average cost of ~$314 (vs UNH’s $321.86 close on 2025-11-14).
• Price Trend
  : UNH’s price ranged from $314.16 to $343.17 in November 2025 (as of 11-14) [0].

• Earnings
  : Q3-2025 earnings are expected on December 4, 2025 [2][4]. The company cut guidance to EPS 2.18-2.23 (vs consensus 2.92) [4].
• China Expansion
  : Plans to reach
  200 stores
  in China, with 25% revenue growth in Mainland China for FY2025 [3].
• Price Trend
  : LULU’s price rebounded 2.93% on 2025-11-14 after recent declines (from $170.2 to $160.66 between Nov 3-4) [0].

• UNH
  : Managed care sector (competitors: CVS Health, Humana).
• LULU
  : Activewear sector (competitors: Alo Yoga, Nike).

• Healthcare ETFs (e.g., XLV) for UNH.
• Consumer Cyclical ETFs (e.g., XLY) for LULU.

1. Berkshire’s Q3 UNH Position
   : The Reddit post references a pre-13F filing—Q3-2025 13F details (whether Berkshire added to UNH) are not publicly available in current data.
2. LULU’s China Deal
   : The post mentions a “potential China deal,” but existing data only references expansion plans (no specific partnership announcement).
3. LULU’s Buybacks
   : The post cites buybacks, but no recent buyback data is available in the tools.
4. UNH’s Regulatory Status
   : Are the Q2 billing investigation and medical cost issues resolved?

• Bullish
  : Attractive price vs Berkshire’s average cost; potential value rotation.
• Bearish
  : Past regulatory/billing risks; recent price underperformance vs sector.

• Bullish
  : China growth (25% YoY revenue); upcoming earnings catalyst.
• Bearish
  : Guidance cut (EPS down ~22% YoY); execution risk for China expansion.

• UNH
  : Unresolved regulatory/billing issues from Q2 could re-emerge [1]. Users should monitor medical cost trends and regulatory updates.
• LULU
  : Earnings miss risk due to guidance cuts; competition in China (local brands like Li-Ning/Anta Sports); execution risk for store expansion [3][4].
• General
  : Market sentiment may shift based on Berkshire’s Q3-2025 13F filing (for UNH) and LULU’s Q3 earnings (Dec4).

1. Berkshire’s Q3 UNH position (once 13F is public).
2. LULU’s Q3 earnings (Dec4) and any China partnership announcements.
3. UNH’s medical cost trends and regulatory updates.
4. LULU’s China expansion progress (store count, revenue growth).

: This analysis is for informational purposes only and not investment advice. Always conduct thorough research before making financial decisions.